Li‐Xun Zhao
- Topics
- Hepatitis C virus research (5 papers)HIV Research and Treatment (4 papers)HIV/AIDS drug development and treatment (4 papers)
- Cited by
- PharmacologyVirology
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Li‐Xun Zhao
20 papers receiving 734 citations
Peers
Comparison fields: 5 of 88
- Pharmacology 299
- Molecular Biology 251
- Epidemiology 124
- Pharmacology 119
- Plant Science 101
Countries citing papers authored by Li‐Xun Zhao
This map shows the geographic impact of Li‐Xun Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xun Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xun Zhao more than expected).
Fields of papers citing papers by Li‐Xun Zhao
This network shows the impact of papers produced by Li‐Xun Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xun Zhao. The network helps show where Li‐Xun Zhao may publish in the future.
Co-authorship network of co-authors of Li‐Xun Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xun Zhao. A scholar is included among the top collaborators of Li‐Xun Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xun Zhao. Li‐Xun Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | 71 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 15 | |
| 7 | 47 | |
| 8 | 10 | |
| 9 | 8 | |
| 10 | 12 | |
| 11 | [Synthesis and antiviral activities of geldanamycin analog TC-GM in vitro]. | 1 |
| 12 | 88 | |
| 13 | 54 | |
| 14 | 6 | |
| 15 | 209 | |
| 16 | 146 | |
| 17 | 10 | |
| 18 | 27 | |
| 19 | 19 | |
| 20 | 8 |
About Li‐Xun Zhao
Li‐Xun Zhao is a scholar working on Microbiology, Virology and Hepatology, having authored 20 papers that have together received 757 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Pharmacology (299 citations), Virology (68 citations) and Pharmacology (119 citations). Li‐Xun Zhao has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Xuefu You, Danqing Song, Jian‐Dong Jiang, Yueming Wang, Weijia Kong, Zhuorong Li, Liyan Yu, Wei Jin, Dawei Shi and Junzheng Wang. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.